BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goldman JG, Guerra CM. Treatment of Nonmotor Symptoms Associated with Parkinson Disease. Neurologic Clinics 2020;38:269-92. [DOI: 10.1016/j.ncl.2019.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang XL, Feng ST, Wang YT, Chen B, Wang ZZ, Chen NH, Zhang Y. Comparative efficacy and acceptability of drug treatments for Parkinson's disease with depression: A systematic review with network meta-analysis. Eur J Pharmacol 2022;:175070. [PMID: 35659968 DOI: 10.1016/j.ejphar.2022.175070] [Reference Citation Analysis]
2 Nabi M, Tabassum N. Role of Environmental Toxicants on Neurodegenerative Disorders. Front Toxicol 2022;4:837579. [DOI: 10.3389/ftox.2022.837579] [Reference Citation Analysis]
3 Hattori N, Kogo Y, Koebis M, Ishida T, Suzuki I, Tsuboi Y, Nomoto M. The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study. Front Neurol 2021;12:752632. [PMID: 35222225 DOI: 10.3389/fneur.2021.752632] [Reference Citation Analysis]
4 Nair SS, Muddapu VR, Chakravarthy VS. A Multiscale, Systems-Level, Neuropharmacological Model of Cortico-Basal Ganglia System for Arm Reaching Under Normal, Parkinsonian, and Levodopa Medication Conditions. Front Comput Neurosci 2022;15:756881. [DOI: 10.3389/fncom.2021.756881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Scorza FA, Guimarães-marques M, Nejm M, de Almeida ACG, Scorza CA, Fiorini AC, Finsterer J. Sudden unexpected death in Parkinson's disease: Insights from clinical practice. Clinics 2022;77:100001. [DOI: 10.1016/j.clinsp.2021.100001] [Reference Citation Analysis]
6 Gupta S, Shukla S. Non-motor symptoms in Parkinson's disease: Opening new avenues in treatment. Current Research in Behavioral Sciences 2021;2:100049. [DOI: 10.1016/j.crbeha.2021.100049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zheng SY, Li HX, Xu RC, Miao WT, Dai MY, Ding ST, Liu HD. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev 2021;69:101347. [PMID: 33905953 DOI: 10.1016/j.arr.2021.101347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
8 Li KP, Zhou ZL, Zhou RZ, Zhu Y, Zhang ZQ. Improvement of freezing of gait in patients with Parkinson's disease by music exercise therapy: a study protocol for a randomized controlled trial. Trials 2021;22:335. [PMID: 33971928 DOI: 10.1186/s13063-021-05258-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Cao H, Han X, Jia Y, Zhang B. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis. Aging (Albany NY) 2021;13:11455-69. [PMID: 33839699 DOI: 10.18632/aging.202837] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
10 Zhi Y, Gao C. Acupuncture in the treatment of fatigue in Parkinson's disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e23389. [PMID: 33235114 DOI: 10.1097/MD.0000000000023389] [Reference Citation Analysis]
11 Park HA, Ellis AC. Dietary Antioxidants and Parkinson's Disease. Antioxidants (Basel) 2020;9:E570. [PMID: 32630250 DOI: 10.3390/antiox9070570] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]